Graniteshares Autocallable Coin ETF ATC
21.46 USD +0.47 (+2.22%)
At closeNov 3, 2026, 4:00 PM EST
23.34 +1.89 +8.80%
After hours · Nov 3, 4:00 PM ET
21.46 Day range 21.60
19.96 52-week range 25.36
- YTD
- -13.41%
- 1 year
- -13.41%
- Market cap
- 831.43K
- YTD return
- -13.41%
- 1-year return
- -13.41%
- Volume
- 300
- Avg volume
- 278
- Open
- 21.60
- Previous close
- 20.99
- Day's range
- 21.46 – 21.60
- 52-week range
- 19.96 – 25.36
- Earnings date
- Aug 9, 2022
2Y -3.99 (-16.10%)
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Aug 9, 2022
Expected Aug 9, 2022. Consensus EPS estimate 0.00.
Financials — quick view
ATC Revenue — quarterly 358.10M
ATC Net income — quarterly 23.60M
ATC EPS — quarterly 0.12
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 9, 2022 | Jun 1, 2022 | 0.00 | — | — | — |
| May 11, 2022 | Mar 1, 2022 | 0.00 | — | — | — |
| Apr 4, 2022 | Dec 1, 2021 | 0.00 | — | — | — |
| Nov 9, 2021 | Sep 1, 2021 | 0.27 | — | — | — |
| Aug 11, 2021 | Jun 1, 2021 | 0.13 | — | — | — |
| May 4, 2021 | Mar 1, 2021 | 0.09 | — | — | — |
News
ATERRA Metals Announces Upsize of Brokered Life Offering to $8,355,000 
ATERRA Metals Announces Brokered Life Offering for up to $6 Million 
ATERRA Metals Reports Maiden Totora Cu-Au Project 
WEC Energy Group Inc (WEC) (Q2 2026) Earnings Call Highlights: Strong EPS Growth and Robust Capital Plan Amid Data Center Demand 
ATERRA Reports Totora Cu/Au Project Drilling Returns 284 m Grading 0.64% CuEq Including 180 m at 0.71% CuEq 
GraniteShares Announces Monthly Distributions for its Autocallable ETFs: ANV, TLA, MSR, ATC, PLA, AHD, SCA and MRA 
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress 
Memo Therapeutics AG Presents Complete Phase II Clinical Trial Data for Potravitug in Kidney Transplant Recipients at the American Transplant Congress 2026 
Natera to Showcase Organ Health Leadership with 21 Presentations at the American Transplant Congress 
Verici Dx Collaborators to Present Data on Predictive Value of Tutivia™ for Acute Kidney Transplant Rejection at ATC 2026
Your note
Sign in to keep a note on ATC — it syncs with the Stock Master app.